US Patent 11963979 Process for T cell expansion

Patent

US Patent 7723107 Pharmaceutical composition for inducing an immune response in a human or animal

US Patent 7745140 Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool

US Patent 7785806 Method for determining the immunogenicity of an antigen

US Patent 7785875 Polynucleotide encoding HCV epitopes which can bind to various HLA supertypes, immunogenic composition comprising same and method of inducing an HCV-specific immune response using same

US Patent 7811581 Epstein Barr Virus (EBV) tumor-associated latent membrane extracellular domain peptides

US Patent 7846446 Multi-epitope peptide-loaded dendritic cell immunotherapy for cancer

US Patent 7951383 Attenuated parainfluenza virus (PIV) vaccines

US Patent 8138314 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations

US Patent 8481051 Cytotoxic T-cell epitope peptides that specifically attack epstein-barr virus-infected cells and uses thereof

US Patent 8546137 Inhibition of dendritic cell-driven regulatory T cell activation and potentiation of tumor antigen-specific T cell responses by interleukin-15 and MAP kinase inhibitor

United States Patent and Trademark Office

Michail A Belyavskyi